Table: Trans Genic -6-MTH group results

TransGenic

05/11/2015 06:15

Nov 5 (Reuters)-  
             Trans Genic Inc  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended       Year to  
                Sep 30, 2015        Sep 30, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            751 mln             717 mln           2.15      
                 (+4.8 pct)          (+27.8 pct)      (+9.8 pct)   
  Operating     loss 133 mln        loss 126 mln        40 mln     
                                                      (+68.8 pct)  
  Recurring     loss 145 mln        loss 132 mln        35 mln     
                                                     (+272.5 pct)  
  Net           loss 104 mln        loss 130 mln        18 mln     
                                                      (+1.0 pct)   
  EPS           loss 7.54 yen       loss 9.53 yen      1.29 yen    
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
   
  NOTE - Trans Genic Inc is a genetic information service company, also engaged in production and sales of antibodies.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2342.T  
  ((Tokyo Headline News Desk +813 6441 1812))